GlaxoSmithKline (France)

394 papers and 17.9k indexed citations i.

About

In recent decades, authors affiliated with GlaxoSmithKline (France) have published 394 papers, which have received a total of 17.9k indexed citations. Scholars at this organization have produced 81 papers in Epidemiology, 69 papers in Pulmonary and Respiratory Medicine and 68 papers in Molecular Biology on the topics of Asthma and respiratory diseases (37 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers) and Health Systems, Economic Evaluations, Quality of Life (24 papers). Their work is cited by papers focused on Molecular Biology (4.8k citations), Epidemiology (3.0k citations) and Surgery (2.7k citations). Authors at GlaxoSmithKline (France) collaborate with scholars in France, United States and United Kingdom and have published in prestigious journals including Nature, Nucleic Acids Research and Journal of Biological Chemistry. Some of GlaxoSmithKline (France)'s most productive authors include Pascal Grondin, Marc C. Hochberg, Roy D. Altman, Jessie McGowan, George A. Wells, Pierre Guy, Tanveer Towheed, Maria Benkhalti, Vivian Welch and Peter Tugwell.

In The Last Decade

Fields of papers published by authors at GlaxoSmithKline (France)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with GlaxoSmithKline (France) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with GlaxoSmithKline (France) at the time of their publication.

Countries citing scholars working at GlaxoSmithKline (France)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at GlaxoSmithKline (France). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at GlaxoSmithKline (France) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GlaxoSmithKline (France) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025